RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

235 hedge funds and large institutions have $10.3B invested in Royalty Pharma in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 57 reducing their positions, and 32 closing their positions.

Holders
235
Holders Change
+23
Holders Change %
+10.85%
% of All Funds
4.1%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.16%
New
56
Increased
91
Reduced
57
Closed
32
Calls
$34.6M
Puts
$48M
Net Calls
-$13.4M
Net Calls Change
-$14.3M

Top Buyers

1
Amundi
1
Amundi
France
$116M
2
Morgan Stanley
2
Morgan Stanley
New York
$2.08B
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$154M
4
Aberdeen Group
4
Aberdeen Group
United Kingdom
$77.2M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$998M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$988M
2
HMC
2
Harvard Management Company
Massachusetts
$293M
3
BlackRock
3
BlackRock
New York
$422M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$931M
5
Victory Capital Management
5
Victory Capital Management
Texas
$51.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$2.08B 50,794,041 +2,675,799 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$998M 24,342,200 +1,829,607 +8%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$988M 24,095,929 -3,856,891 -14%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$931M 22,721,815 -1,965,941 -8%
Capital International Investors
5
Capital International Investors
California
$694M 16,942,708 +493,607 +3%
BlackRock
6
BlackRock
New York
$422M 10,287,641 -3,376,940 -25%
VCG
7
Vantage Consulting Group
Virginia
$381M 9,302,445 +596,894 +7%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$300M 7,315,001 +1,519,734 +26%
HMC
9
Harvard Management Company
Massachusetts
$293M 7,142,856 -3,571,428 -33%
SGA
10
Siguler Guff Advisers
New York
$277M 6,761,970 – –
State Street
11
State Street
Massachusetts
$200M 4,867,634 +181,771 +4%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$176M 4,303,526 -589,607 -12%
Janus Henderson Group
13
Janus Henderson Group
United Kingdom
$154M 3,745,414 +2,505,360 +202%
Viking Global Investors
14
Viking Global Investors
Connecticut
$133M 3,238,654 +1,176,901 +57%
Amundi
15
Amundi
France
$116M 2,828,265 +2,828,265 New
Norges Bank
16
Norges Bank
Norway
$115M 2,794,952 +31,815 +1%
MSKCC
17
Memorial Sloan Kettering Cancer Center
New York
$110M 2,680,644 – –
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$90.2M 2,199,853 -154,365 -7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$81.2M 1,984,686 +54,236 +3%
Aberdeen Group
20
Aberdeen Group
United Kingdom
$77.2M 1,884,011 +1,855,388 +6,482%
Bank of America
21
Bank of America
North Carolina
$65.3M 1,592,556 +166,677 +12%
TCM
22
TimesSquare Capital Management
New York
$61.5M 1,501,560 +85,945 +6%
GA
23
General Atlantic
New York
$61.5M 1,500,000 – –
Legal & General Group
24
Legal & General Group
United Kingdom
$60.3M 1,471,237 +68,665 +5%
EVM
25
Eaton Vance Management
Massachusetts
$56.7M 1,383,073 +374,100 +37%
1
2 3 4 5